title: From NETTER to PETTER: PSMA-Targeted Radioligand Therapy.
authors.affiliation: Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany matthias.eiber@gmx.de.|Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and.
authors.forename: Matthias
authors.initials: M
authors.lastname: Eiber
authors.affiliation: Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany.
authors.forename: Ken
authors.initials: K
authors.lastname: Herrmann
mesh_terms: D004151:Dipeptides; D006573:Heterocyclic Compounds, 1-Ring; D006801:Humans; D008187:Lutetium; D008297:Male; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms
chemical_list: C000610110:Pluvicto; D004151:Dipeptides; D006573:Heterocyclic Compounds, 1-Ring; D008187:Lutetium; D017430:Prostate-Specific Antigen